Guidelines for the Pharmacological Management of Overactive Bladder Disease in Adults in Primary Care

  • Version
  • Download 9308
  • File Size 1.03 MB
  • File Count 1
  • Create Date November 4, 2020
  • Last Updated February 22, 2022

Guidelines for the Pharmacological Management of Overactive Bladder Disease in Adults in Primary Care

Overactive Bladder (OAB)

Mirabegron

NICE TA290

Betmiga

Regurin

Vesicare

Detrunorm

Detrusitol

Lyrinel

Toviaz

Fesoteradine

Ditropan

Tolterodine

Oxybutynin

Oxybutynin MR

Trospium

Solifenacin

Mirabegron

Attached Files

FileAction
OAB guidance minor update Feb 2022 FINAL.pdfDownload